1. Genetic alteration of histone lysine methyltransferases and their significance in renal cell carcinoma
   Libin Yan et al, 2019, PeerJ CrossRef
2. SETD2 Haploinsufficiency for Microtubule Methylation Is an Early Driver of Genomic Instability in Renal Cell Carcinoma
   Yun-Chen Chiang et al, 2018, Cancer Research CrossRef
3. Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
   Emily Pulford et al, 2017, Disease Markers CrossRef
4. Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation‐dependent probe amplification
   Yoshie Yoshikawa et al, 2022, Cancer Science CrossRef
5. Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer
   Takashi Hirosawa et al, 2018, PLOS ONE CrossRef
6. Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer
   Michele Carbone et al, 2020, Cancer Discovery CrossRef
7. Renal Cell Carcinoma: Molecular Aspects
   Aman Kumar et al, 2018, Indian Journal of Clinical Biochemistry CrossRef
8. BRCA1-Associated Protein 1 (BAP-1) as a Prognostic and Predictive Biomarker in Clear Cell Renal Cell Carcinoma: A Systematic Review
   Shuchi Gulati et al, 2022, Kidney Cancer CrossRef